Expanding Access – Optimizing Use of Long-Acting Injectable PrEP
Long-acting injectable (LAI) pre-exposure prophylaxis (PrEP) represents a major advancement in HIV prevention, offering new opportunities to support adherence and reduce transmission, yet its optimal use remains underrealized across global healthcare settings. Many HIV/infectious disease specialists, primary care clinicians, and …